Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>Results of clinical trials for &ldquo;stalled&rdquo; neurological drugs &mdash; those which had at least one completed Phase III trial but failed to receive FDA approval &mdash; are heavily underreported, found a new study.</p>

Study: Trial Results for New Neurological Drugs Often Go Unpublished